Phase 2 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are attending a routine screening procedure using a special dye (called Lugol's solution) to check for a type of cancer called squamous cell neoplasia in the esophagus (food pipe).
- People who have a history of head or neck squamous cell cancer, or who have risk factors such as heavy smoking, heavy alcohol use, certain dietary or geographic risk factors, or a previous diagnosis of abnormal cells (dysplasia).
- People who are older than 18 years of age.
- People of any sex or gender.
- People who are willing and able to give their informed consent to take part.
Who may not be able to join:
- People who have a known allergy or have had a previous reaction to a fluorescent dye called proflavine hemisulfate.
- People who are unable to give informed consent.
- People who have a known advanced squamous cell cancer in the lower part of the esophagus, or an abnormal or suspected cancerous lesion in the esophagus that is 2 cm or larger in size and cannot be treated with an endoscopic (camera-based) procedure.
- People who are pregnant or breastfeeding.
- People whose blood does not clot properly, based on specific blood test results (confirm with trial site).
- People who are unable to safely undergo a sedated upper endoscopy (a camera examination of the food pipe under sedation) due to heart or lung instability or other serious health conditions.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mimi C Tan, MD, MPH, Baylor College of Medicine
Phone: 7137980950
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical Impact; Performance Characteristics; Procedure Efficiency; Clinician Confidence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.